Your browser doesn't support javascript.
loading
Multifunctional nanorods based on self-assembly of biomimetic apolipoprotein E peptide for the treatment of Alzheimer's disease.
Zhang, Shanshan; Asghar, Sajid; Zhu, Chenqi; Ye, Junxiu; Lin, Ling; Xu, Liu; Hu, Ziyi; Chen, Zhipeng; Shao, Feng; Xiao, Yanyu.
Afiliación
  • Zhang S; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China; School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Asghar S; Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan.
  • Zhu C; Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215002, PR China.
  • Ye J; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
  • Lin L; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
  • Xu L; Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China.
  • Hu Z; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
  • Chen Z; Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China. Electronic address: czpcpu2000@hotmail.com.
  • Shao F; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China. Electronic address: jsphshaofeng@hotmail.com.
  • Xiao Y; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: cpuyanyuxiao@163.com.
J Control Release ; 335: 637-649, 2021 07 10.
Article en En | MEDLINE | ID: mdl-34087249
ABSTRACT
Targeting a single molecule or a single pathway and poor drug delivery to the brain hamper the therapy of Alzheimer's disease (AD) based on abnormal metabolism of amyloid-ß (Aß). To solve these problems, we designed and synthesized a multi - strategy peptide (MOP), an ingenious apolipoprotein E mimetic peptide, which could reduce Aß deposition via inhibiting Aß aggregation and at the same time accelerate Aß clearance. Meanwhile, MOP could be self-assembled into different nanostructure, thus we constructed a multifunctional delivery system (APND-3) based on MOP self-assembled nanorods (aspect ratios of 3) that was a favorable morphology to enhance the permeation across the blood brain barrier (BBB) to address the poor delivery to brain issues. Besides, the drug delivery system introduces polydopamine (PDA) and COG1410 ligand as a shell to keep the favorable morphology of core and enhance the BBB targeting efficiency. As a result, the delivery system significantly enhances the delivery of MOP to the brain, thus reducing Aß deposition, mitigating the memory deficits, and ameliorating neurologic damage in AD model mice. Our findings suggest that our drug and carrier integrated multifunctional delivery system has the potential for AD treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanotubos / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanotubos / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China
...